A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Modified Citrus Pectin | MCP. CAS No. 9000-69-5. Product ID: 4-00681. Properties: from sterculia tree. |  |
| Modified defensin | Modified defensin is a synthetic construct peptide and has antibacterial activity. |  |
| Modified Starch Coated Calcium Carbonate | Modified Starch Coated Calcium Carbonate. |  |
| Modified Starches | Modified Starches. CAS No. 68412-35-1. Product ID: PE-0339. Category: Excipients. Product Keywords: Pharmaceutical Excipients; Excipients; Modified Starches; PE-0339; 68412-35-1; 68412-35-1. Standard: In-house standard. Grade: Pharmaceutical grade. |  |
| Modified T7 RNA polymerase | A modified T7 RNA polymerase that orthogonally recognizes a non-natural promoter sequence: 5-TAATACCGGTCACTATA, where the underlined residues differ from wild-type. Group: Enzymes. Synonyms: CGG-R12-KIR. Enzyme Commission Number: EC 2.7.7.6. CAS No. 9014-24-8. Purity: > 98% (SDS-PAGE). Mole weight: 100.142 kDa. Storage: at -20 °C. Form: Liquid. CGG-R12-KIR; Non-Natural Promoter T7 Polymerase; modified T7 RNA polymerase; T7 RNA polymerase. Cat No: NATE-1698. |  |
| Modipafant | This active molecular is a dihydropyridine Platelet-Activating Factor (PAF) antagonist under the development of Pfizer. In Sep 2015, treatment for Asthma in USA was discontinued. In Sep 2015, Phase-I clinical trials in Dengue in USA was on-going. Uses: Dengue;asthma. Synonyms: UK-80067; UK 80067; UNII-1DMI0E5023;122957-06-6;UK80067;AC1MILSU;(R)-ethyl 4-(2-chlorophenyl)-6-methyl-2-(4-(2-methyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl)-5-(pyridin-2-ylcarbamoyl)-1,4-dihydropyridine-3-carboxylate. Grades: 95%. CAS No. 122957-06-6. Molecular formula: C34H29ClN6O3. Mole weight: 605.09. | |
| Modotuximab | Modotuximab (DS 1024) is an IgG1κ-type chimeric antibody targeting human EGFR protein. Modotuximab binds non-overlapping epitopes on domain III of EGFR, a domain that is intact in EGFRvIII. Modotuximab has antitumor activity in vivo [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: DS 1024. CAS No. 1310460-86-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99306. |  |
| Moenomycin Complex | Moenomycin complex is a mixture of five major components: A, A12, C1, C3 and C4 isolated from several strains of Streptomyces in the 1960s. Moenomycins are high molecular weight phosphoglycolipids with potent antibiotic activity used in animal health. Moenomycins are the only antibiotic known to selectively inhibit the transglycosylation step catalyzed by penicillin-binding protein 1b. Group: Biochemicals. Alternative Names: Streptomyces A, A12, C1, C3 and C4. Grades: Highly Purified. CAS No. 11015-37-5. Pack Sizes: 5mg. Molecular Formula: C69H107N4O35P, Molecular Weight: ~1583.6. US Biological Life Sciences. |  Worldwide |
| Moexipril | Moexipril is a potent orally active nonsulfhydryl angiotensin converting enzyme(ACE) inhibitor with antihypertensive activity. It is used for the treatment of hypertension and congestive heart failure. It prevents the actions of the potent vasoconstrictor angiotensin II and leads to vasodilation. It also prevents angiotensin II-induced aldosterone secretion by the adrenal cortex, thereby promoting diuresis and natriuresis. lt was developed by Schwarz Pharma and has been listed. Uses: Moexipri is used for the treatment of hypertension and congestive heart failure. Synonyms: 2-[2-[(1-Ethoxycarbonyl-3-phenyl-propyl)amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;(3S)-2-[(2S)-2-[[(1S)-1-carbethoxy-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;RS 10085; RS-10085;SPM-925;CI-925; RS 10085;SPM 925;CI 925; RS10085;SPM925;CI925. Grades: 98%. CAS No. 103775-10-6. Molecular formula: C27H34N2O7. Mole weight: 498.57. | |
| Moexipril acyl-b-D-glucuronide | Moexipril acyl-b-D-glucuronide is an essential compound deployed within the biomedical sector, serving as an active metabolite of the revered antihypertensive medication, moexipril. Its multifaceted prowess extends to the research of disorders encompassing hypertension with the suppression of angiotensin-converting enzyme (ACE). Synonyms: (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-D5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylate b-D-glucopyranuronic acid. Molecular formula: C33H42N2O13. Mole weight: 674.69. | |
| Moexipril Acyl Glucuronide | Labelled Moexiprilat, which an angiotensin converting enzyme inhibitor. Synonyms: Moexipril Acyl-β-D-glucuronide; (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylate β-D-Glucopyranuronic Acid. Grades: > 95%. Molecular formula: C31H38N2O13. Mole weight: 646.65. | |
| Moexiprilat | Moexiprilat is an angiotensin converting enzyme inhibitor. Synonyms: (3S)-2-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylicacid; Moexiprilat; MoexiprilatHydrate. Grades: > 95%. CAS No. 103775-14-0. Molecular formula: C25H30N2O7. Mole weight: 470.53. | |
| Moexiprilat acyl D-glucuronide | | |
| Moexiprilat-d5 (2-[2-(1-Carboxy-3-phenyl-d5-propylamino)-propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic Acid) | Labeled analogue of Quinapril. Group: Biochemicals. Alternative Names: 2-[2-(1-Carboxy-3-phenyl-d5-propylamino)-propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic Acid. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Moexiprilat Hydrate (2-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic Acid Hydrate) | Analogue of Quinapril. Group: Biochemicals. Alternative Names: 2-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic Acid Hydrate. Grades: Highly Purified. CAS No. 103775-14-0. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Moexipril Cyclohexyl Analogue Hydrochloride | An impurity of Moexipril. Group: Biochemicals. Alternative Names: (S)-2-{(S)-2-[(S)-4-Cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Moexipril-d5 ((3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid, RS-10085-d5) | Angiotensin converting enzyme (ACE) inhibitor; dimethoxy analog of quinapril. Group: Biochemicals. Alternative Names: (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid; RS-10085-d5. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Moexipril Diketopiperazine | An impurity of Moexipril. The degradation kinetics of Moexipril produced by organic solvents. Group: Biochemicals. Alternative Names: (αS,3S,11aS)-1,3,4,6,11,11a-Hexahydro-8,9-dimethoxy-3-methyl-1,4-dioxo-α-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetic Acid Ethyl Ester; [3S-[2(R*),3α,11a β]]-1,3,4,6,11,11a-Hexahydro-8,9-dimethoxy-3-methyl-1,4-dioxo-α-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetic Acid Ethyl Ester; PD 114009. Grades: Highly Purified. CAS No. 103733-51-3. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moexipril HCl | Moexipril HCl is a potent orally active non-sulfhydryl angiotensin converting enzyme inhibitor (ACE) with IC50 of 0.041 μM, which is used for the treatment of hypertension and congestive heart failure. Uses: Angiotensin-converting enzyme inhibitors. Synonyms: CI-906, PD-109452-2; CI 906, PD 109452-2; CI906, PD109452-2. Grades: >98%. CAS No. 82586-52-5. Molecular formula: C27H35ClN2O7. Mole weight: 535.03. | |
| Moexipril hydrochloride | Moexipril hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 82586-52-5. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Moexipril hydrochloride | Moexipril hydrochloride (RS-10085) is an orally active inhibitor of angiotensin-converting enzyme ( ACE ), and becomes effective by being hydrolyzed to moexiprila (hydrochloride). Moexipril hydrochloride exhibits antihypertensive and neuroprotective effects [1] - [4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: RS-10085. CAS No. 82586-52-5. Pack Sizes: 10 mM * 1 mL; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0378A. | |
| Moexipril Hydrochloride ((3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride, CI-925, RS-10085-197, SPM-925, Fempress, Perdix, Univasc) | Angiotensin converting enzyme (ACE) inhibitor; dimethoxy analog of quinapril. Group: Biochemicals. Alternative Names: (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride; CI-925; RS-10085-197; SPM-925; Fempress; Perdix; Univasc. Grades: Highly Purified. CAS No. 82586-52-5. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moexipril Methyl Benzyl Ester Maleate | Moexipril derivative. Group: Biochemicals. Alternative Names: [3S-[2-(S),3S]]-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[2-[[1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-3-isoquinolinecarboxylic Acid Benzyl Ester Maleate. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moexipril Methyl Ester Analog Hydrochloride Salt | An impurity of Moexipril. Group: Biochemicals. Alternative Names: [3S-[2-(S),3S]]-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[2-[[1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-3-isoquinolinecarboxylic Acid Hydrochloride. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moexipril Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. |  |
| Moexipril Related Compound B | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound C | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound D | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound E | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound F | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril Related Compound G | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moexipril tert-Butyl Ester Maleic Acid Salt | An impurity of Moexipril. Group: Biochemicals. Alternative Names: (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid 1,1-Dimethylethyl Ester; (2Z)-2-Butenedioate. Grades: Highly Purified. CAS No. 103733-40-0. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| MOF | MOF. Group: Carboxylic acid nitrogen-containing mixed mof ligand-multiple mixed ligand. Molecular formula: white powder. |  |
| MOF&1,1',1'',1'''-ethene-1,1,2,2-tetrayltetrakis(4-methylbenzene) | MOF&1,1',1'',1'''-ethene-1,1,2,2-tetrayltetrakis(4-methylbenzene). Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-tetra-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1,1':2',1''-Terphenyl, 4,4''-dibromo-3',4',5',6'-tetrakis(4-bromophenyl)- | MOF&1,1':2',1''-Terphenyl, 4,4''-dibromo-3',4',5',6'-tetrakis(4-bromophenyl)-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-triphenylbenzene. Pack Sizes: 20 mg. | |
| MOF&1,1',2,2'-tetrakis(4-bromophenyl)ethene | MOF&1,1',2,2'-tetrakis(4-bromophenyl)ethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-tetra-substituted tpe. Pack Sizes: 50 mg. | |
| MOF&1,1,2-Triphenyl-2-(4- bromomethylphenyl)ethylene | MOF&1,1,2-Triphenyl-2-(4- bromomethylphenyl)ethylene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1, 1'-(5'-(4-acetylphenyl)-[1, 1':3', 1''-terphenyl]-4, 4''-diyl)diethanone | MOF&1, 1'-(5'-(4-acetylphenyl)-[1, 1':3', 1''-terphenyl]-4, 4''-diyl)diethanone. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-triphenylbenzene. Pack Sizes: 50 mg. | |
| MOF&[1, 1'-Binaphthalene]-2, 2'-diamine | MOF&[1, 1'-Binaphthalene]-2, 2'-diamine. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 10mL. Product ID: 1-(2-aminonaphthalen-1-yl)naphthalen-2-amine. Molecular formula: 284.4g/mol. Mole weight: C20H16N2. InChI=1S / C20H16N2 / c21-17-11-9-13-5-1-3-7-15 (13) 19 (17) 20-16-8-4-2-6-14 (16) 10-12-18 (20) 22 / h1-12H, 21-22H2. DDAPSNKEOHDLKB-UHFFFAOYSA-N. | |
| MOF&[1,1-bis(4-N,N-dimethylphenyl)-2,2-bis(4-bromophenyl)]ethylene | MOF&[1,1-bis(4-N,N-dimethylphenyl)-2,2-bis(4-bromophenyl)]ethylene. Group: Organic-linker blocks-bi-substituted tpe. | |
| MOF&1,1-diphenyl-2,2-di(4-bromomethyl-phenyl)ethylene | MOF&1,1-diphenyl-2,2-di(4-bromomethyl-phenyl)ethylene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 20 mg. | |
| MOF&1,1-diphenyl-2,2-di(p-bromophenyl)ethylene | MOF&1,1-diphenyl-2,2-di(p-bromophenyl)ethylene. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: Customized service. | |
| MOF&1,2-Benzenedicarbonitrile, 4,5-diamino- | MOF&1,2-Benzenedicarbonitrile, 4,5-diamino-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 20 mg. | |
| MOF&1,2-Bis[4-(bromomethyl)phenyl]-1,2-diphenylethene | MOF&1,2-Bis[4-(bromomethyl)phenyl]-1,2-diphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. Product ID: 1-(bromomethyl)-4-[(E)-2-[4-(bromomethyl)phenyl]-1,2-diphenylethenyl]benzene. Molecular formula: 518.3g/mol. Mole weight: C28H22Br2. InChI=1S / C28H22Br2 / c29-19-21-11-15-25 (16-12-21) 27 (23-7-3-1-4-8-23) 28 (24-9-5-2-6-10-24) 26-17-13-22 (20-30) 14-18-26 / h1-18H, 19-20H2 / b28-27+. GHZTXESUSOBGAM-BYYHNAKLSA-N. | |
| MOF&1,2-Bis(4-bromophenyl)-1,2-diphenylethene | MOF&1,2-Bis(4-bromophenyl)-1,2-diphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. Product ID: 1-bromo-4-[(E)-2-(4-bromophenyl)-1,2-diphenylethenyl]benzene. Molecular formula: 490.2g/mol. Mole weight: C26H18Br2. InChI=1S/C26H18Br2/c27-23-15-11-21 (12-16-23)25 (19-7-3-1-4-8-19)26 (20-9-5-2-6-10-20)22-13-17-24 (28)18-14-22/h1-18H/b26-25+. BBSNJTOHVHUCRF-OCEACIFDSA-N. | |
| MOF&1,2-Bis(4-hydroxyphenyl)-1,2-diphenylethylene | MOF&1,2-Bis(4-hydroxyphenyl)-1,2-diphenylethylene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1,2-di-[4-(aminomethyl)phenyl]-1,2-diphenylethylene | MOF&1,2-di-[4-(aminomethyl)phenyl]-1,2-diphenylethylene. Group: Organic-linker blocks-bi-substituted tpe. | |
| MOF&1,2-Di(4-carboxyphenyl)-1,2,2-triphenylethene | MOF&1,2-Di(4-carboxyphenyl)-1,2,2-triphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Carboxylic acid mof ligand-dicarboxylic acid mof ligand. Pack Sizes: 20 mg. | |
| MOF&[1,2-diphenyl-1,2-bis(4-cyanophenyl)ethylene | MOF&[1,2-diphenyl-1,2-bis(4-cyanophenyl)ethylene. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10mL. | |
| MOF&1,2-Ethanediamine, N,N-bis(2-pyridinylmethyl)- | MOF&1,2-Ethanediamine, N,N-bis(2-pyridinylmethyl)-. Group: Organic-linker blocks- other linker blocks. | |
| MOF&1-(2-Propyn-1-yloxy)-4-(1,2,2-triphenylethenyl)benzene | MOF&1-(2-Propyn-1-yloxy)-4-(1,2,2-triphenylethenyl)benzene. Uses: Composite materials, bio-labeling, optoelectronic devices, fluorescence materials etc. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 50 ml. | |
| MOF&1,3,2-Dioxaborolane, 2,2'-[(1,2-diphenyl-1,2-ethenediyl)di-4,1-phenylene]bis[4,4,5,5-tetramethyl- | MOF&1,3,2-Dioxaborolane, 2,2'-[(1,2-diphenyl-1,2-ethenediyl)di-4,1-phenylene]bis[4,4,5,5-tetramethyl-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-bi-substituted tpe. Pack Sizes: 10 mg. | |
| MOF&1,3,5-Triazine, 2,4,6-tris(3,5-dimethyl-1H-pyrazol-1-yl)- | MOF&1,3,5-Triazine, 2,4,6-tris(3,5-dimethyl-1H-pyrazol-1-yl)-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Nitrogen-containing mof ligand-ternary nitrogen-containing mof ligand. CAS No. 154403-27-7. Pack Sizes: 20 mg. Product ID: 2,4,6-tris(3,5-dimethylpyrazol-1-yl)-1,3,5-triazine. Molecular formula: 363.4g/mol. Mole weight: C18H21N9. InChI=1S/C18H21N9/c1-10-7-13 (4)25 (22-10)16-19-17 (26-14 (5)8-11 (2)23-26)21-18 (20-16)27-15 (6)9-12 (3)24-27/h7-9H, 1-6H3. DGBHCVCPUCYWEM-UHFFFAOYSA-N. | |
| MOF&1,3,5-Tris(4-bromophenyl)benzene | MOF&1,3,5-Tris(4-bromophenyl)benzene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-triphenylbenzene. Pack Sizes: 10 mg. Product ID: 1,3,5-tris(4-bromophenyl)benzene. Molecular formula: 543.1g/mol. Mole weight: C24H15Br3. InChI=1S/C24H15Br3/c25-22-7-1-16 (2-8-22)19-13-20 (17-3-9-23 (26)10-4-17)15-21 (14-19)18-5-11-24 (27)12-6-18/h1-15H. HJQRITCAXSBOPC-UHFFFAOYSA-N. | |
| MOF&1,3,6,8-Tetrabromopyrene | MOF&1,3,6,8-Tetrabromopyrene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-halide substituted aromatics. Pack Sizes: 10 mg. Product ID: 1,3,6,8-tetrabromopyrene. Molecular formula: 517.8g/mol. Mole weight: C16H6Br4. InChI=1S/C16H6Br4/c17-11-5-13 (19)9-3-4-10-14 (20)6-12 (18)8-2-1-7 (11)15 (9)16 (8)10/h1-6H. ZKBKRTZIYOKNRG-UHFFFAOYSA-N. | |
| MOF&1, 3- Benzenedicarboxylic acid, 5- borono- | MOF&1, 3- Benzenedicarboxylic acid, 5- borono-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- isophthalate. Pack Sizes: 20 mg. | |
| MOF&1-(4-Aminophenyl)-1,2,2-triphenylethene | MOF&1-(4-Aminophenyl)-1,2,2-triphenylethene. Uses: Na. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 100 mg. | |
| MOF&1-(4-Bromophenyl)-1,2,2-triphenylethene | MOF&1-(4-Bromophenyl)-1,2,2-triphenylethene. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 50 ml. Product ID: 1-bromo-4-(1,2,2-triphenylethenyl)benzene. Molecular formula: 411.3g/mol. Mole weight: C26H19Br. InChI=1S/C26H19Br/c27-24-18-16-23 (17-19-24) 26 (22-14-8-3-9-15-22) 25 (20-10-4-1-5-11-20) 21-12-6-2-7-13-21/h1-19H. MYJLJYSALGARCM-UHFFFAOYSA-N. | |
| MOF&1,4-Dibromo-2,5-diiodobenzene | MOF&1,4-Dibromo-2,5-diiodobenzene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-halide substituted aromatics. Pack Sizes: 10 mg. Product ID: 1,4-dibromo-2,5-diiodobenzene. Molecular formula: 487.70g/mol. Mole weight: C6H2Br2I2. InChI=1S/C6H2Br2I2/c7-3-1-5 (9)4 (8)2-6 (3)10/h1-2H. IVKPEQAIHJWGGT-UHFFFAOYSA-N. | |
| MOF&1-(4-Hydroxyphenyl)-1,2,2-triphenylethene | MOF&1-(4-Hydroxyphenyl)-1,2,2-triphenylethene. Group: Organic-linker blocks-1-substituted tpe. | |
| MOF&1-(4-phenylboronic acid pinacol ester)-1,2,2-triphenylethene | MOF&1-(4-phenylboronic acid pinacol ester)-1,2,2-triphenylethene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-1-substituted tpe. Pack Sizes: 50 mg. | |
| MOF&1,5-dibromo-2,4-bis(bromomethyl)benzene | MOF&1,5-dibromo-2,4-bis(bromomethyl)benzene. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-halide substituted aromatics. Pack Sizes: 10 mg. Product ID: 1,5-dibromo-2,4-bis(bromomethyl)benzene. Molecular formula: 421.75g/mol. Mole weight: C8H6Br4. InChI=1S/C8H6Br4/c9-3-5-1-6 (4-10)8 (12)2-7 (5)11/h1-2H, 3-4H2. UYNPUSPGNRCVLC-UHFFFAOYSA-N. | |
| MOF&1H,1'H-2,2'-Biimidazole | MOF&1H,1'H-2,2'-Biimidazole. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 10 mg. Product ID: 2-(1H-imidazol-2-yl)-1H-imidazole. Molecular formula: 134.14g/mol. Mole weight: C6H6N4. InChI=1S/C6H6N4/c1-2-8-5 (7-1)6-9-3-4-10-6/h1-4H, (H, 7, 8) (H, 9, 10). AZUHIVLOSAPWDM-UHFFFAOYSA-N. | |
| MOF&1H- Imidazole, 1, 1', 1'', 1'''- (1, 2- ethenediylidenetetra - 4, 1- phenylene) tetrakis- | MOF&1H- Imidazole, 1, 1', 1'', 1'''- (1, 2- ethenediylidenetetra - 4, 1- phenylene) tetrakis-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks-tetra-substituted tpe. Pack Sizes: 50 mg. | |
| MOF&1-oxido-N-[(1-oxopyridin-1-ium-4-ylidene)amino]pyridin-4-imine | MOF&1-oxido-N-[(1-oxopyridin-1-ium-4-ylidene)amino]pyridin-4-imine. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 10 mg. | |
| MOF&21H, 23H- Porphine, 5, 10, 15, 20- tetra- 1H- pyrazol- 4- yl- | MOF&21H, 23H- Porphine, 5, 10, 15, 20- tetra- 1H- pyrazol- 4- yl-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Customizable mof linkers. Pack Sizes: 50mg. | |
| MOF&21H, 23H- Porphine, 5, 10, 15, 20- tetra- 3- pyridinyl- | MOF&21H, 23H- Porphine, 5, 10, 15, 20- tetra- 3- pyridinyl-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Customizable mof linkers. Pack Sizes: 16 mg. | |
| MOF&2,2'-((2,2-diphenylethene-1,1-diyl)bis(4,1-phenylene))bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) | MOF&2,2'-((2,2-diphenylethene-1,1-diyl)bis(4,1-phenylene))bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane). Group: Organic-linker blocks- other linker blocks. Product ID: 2-[4-[2,2-diphenyl-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. Molecular formula: 584.4g/mol. Mole weight: C38H42B2O4. InChI=1S/C38H42B2O4/c1-35 (2) 36 (3, 4) 42-39 (41-35) 31-23-19-29 (20-24-31) 34 (33 (27-15-11-9-12-16-27) 28-17-13-10-14-18-28) 30-21-25-32 (26-22-30) 40-43-37 (5, 6) 38 (7, 8) 44-40/h9-26H, 1-8H3. SIBUCPJWEIWPQT-UHFFFAOYSA-N. | |
| MOF&2,2':6',2''-Terpyridine,4'-(4-chlorophenyl)- | MOF&2,2':6',2''-Terpyridine,4'-(4-chlorophenyl)-. Uses: Up conversion nanoparticles have excellent optical stability. they have been widely applied in biomedicine, including in vivo bioimaging, in vivo bioimaging, biodetection, immunohistochemistry, microarray detection, photodynamic therapy, and photoactivated drug activation. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 10 mg. Product ID: 4-(4-chlorophenyl)-2,6-dipyridin-2-ylpyridine. Molecular formula: 343.8g/mol. Mole weight: C21H14ClN3. InChI=1S/C21H14ClN3/c22-17-9-7-15 (8-10-17)16-13-20 (18-5-1-3-11-23-18)25-21 (14-16)19-6-2-4-12-24-19/h1-14H. UPOMZZQMFGCHGB-UHFFFAOYSA-N. | |
| MOF&[2, 2'-Bipyridine]-3, 3'-dicarboxylicacid, 3,3'-dimethyl ester | MOF&[2, 2'-Bipyridine]-3, 3'-dicarboxylicacid, 3,3'-dimethyl ester. Uses: Na. Group: Organic-linker blocks- other linker blocks. Pack Sizes: 100mg. | |
Our database is helping our users find suppliers everyday.
